title: Branched-chain amino acids inhibit the TGF-beta-induced down-regulation of taurine biosynthetic enzyme cysteine dioxygenase in HepG2 cells.
abstract: Taurine deficiency has been suggested to contribute to the pathogenesis and complications of advanced hepatic diseases. The molecular basis for a low level of taurine associated with hepatic failure is largely unknown. Using carbon tetrachloride (CCl4)-induced cirrhotic rat model, we found that the activity and expression of cysteine dioxygenase (CDO), a rate-limiting enzyme in taurine synthesis, were significantly decreased in the liver of these rats. To investigate the underlying mechanisms for the suppression, we examined the effects of pathological cytokines on CDO expression in human hepatoma HepG2 cells. Among the several cytokines, transforming growth factor-β (TGF-β), one of the key mediators of fibrogenesis, suppressed Cdo1 gene transcription through the MEK/ERK pathway. Finally, we further examined potential effects of branched-chain amino acids (BCAA) on CDO expression, as it has been reported that oral BCAA supplementation increased plasma taurine level in the patients with liver cirrhosis. BCAA, especially leucine, promoted Cdo1 gene transcription, and attenuated TGF-β-mediated suppression of Cdo1 gene expression. These results indicate that the low plasma level of taurine in advanced hepatic disease is due to decreased hepatic CDO expression, which can be partly attributed to suppressive effect of TGF-β on Cdo1 gene transcription. Furthermore, our observation that BCAA promotes Cdo1 expression suggests that BCAA may be therapeutically useful to improve hepatic taurine metabolism and further suppress dysfunctions associated with low level of taurine in hepatic diseases.
authors.affiliation: Research Institute, Ajinomoto Pharmaceuticals Co. Ltd., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki, 210-8681, Japan.
authors.forename: Asami
authors.initials: A
authors.lastname: Hagiwara
authors.forename: Sonoko
authors.initials: S
authors.lastname: Ishizaki
authors.forename: Kenji
authors.initials: K
authors.lastname: Takehana
authors.forename: Shoji
authors.initials: S
authors.lastname: Fujitani
authors.forename: Ichiro
authors.initials: I
authors.lastname: Sonaka
authors.forename: Hideo
authors.initials: H
authors.lastname: Satsu
authors.forename: Makoto
authors.initials: M
authors.lastname: Shimizu
mesh_terms: D000597:Amino Acids, Branched-Chain / Q000378:metabolism*; D000818:Animals; D050558:Cysteine Dioxygenase / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D015536:Down-Regulation; D056945:Hep G2 Cells; D006801:Humans; D008103:Liver Cirrhosis / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013654:Taurine / Q000096:biosynthesis*; D053773:Transforming Growth Factor beta1 / Q000378:metabolism*
chemical_list: D000597:Amino Acids, Branched-Chain; C508960:TGFB1 protein, human; D053773:Transforming Growth Factor beta1; D013654:Taurine; D050558:Cysteine Dioxygenase